About Us

Engineering scientific technology for the global advancement of male fertility. Androvia LifeSciences is a biotechnology company focused on solving male fertility issues.
  • Our Company
  • CEO’s Message
  • Our Team

Androvia LifeSciences is a biotechnology company focused on solving male fertility issues.

Androvia LifeSciences is among only a few companies in the world researching male fertility today. Powered by Dr. Alex Travis’ groundbreaking discoveries on the physiology of sperm, Androvia is focused on empowering men with the information to help them find potential fertility solutions.

There have been very few clinically significant advances in determining the cause of male fertility in the last two decades. Androvia was founded to change that.

Androvia has developed a novel, proprietary biomarker-based assay that assesses the functional ability of sperm to fertilize an egg. While other male fertility tests determine sperm count, motility and appearance, we believe Androvia’s test is the only test capable of helping to determine if the sperm is able to fertilize an egg. Specifically, this laboratory-developed test evaluates capacitation, the physiological cascade undergone by sperm in the female reproductive tract that enables the sperm to fertilize an egg.

Androvia’s cutting-edge technology, the Cap-Score™ Assay, is designed to help couples make informed decisions about their fertility.

Dear Friends,

One of the greatest gifts we can receive is a child. Having the ability to conceive a child is a gift just as great as the child itself. Around the world, there are millions of couples who desperately want this gift but are deprived of this experience despite their best efforts and the support of educated, impassioned medical professionals.

I have spent more than 23 years in this field and have had the privilege of witnessing the joys and, yes, the sorrows within the hearts of couples trying so desperately to have children. The emotional pain of those who cannot conceive is excruciating.

Although both the woman and the man are part of this rigorous process to conceive, it has always perplexed me why medical research and psychological attention has largely neglected the man. While infertility impacts men and women equally, industry has failed to pay attention to the underlying causes of male infertility. Current tests often do not give medical professionals enough information to explain the cause of a man’s infertility, which can be extremely frustrating and emotionally challenging.

In 2013, I was given the opportunity to spearhead an effort to introduce a game changing technology that would not only focus on this neglected part of research, but also initiate a transformation in how the community views fertility treatment options.

The ground breaking research that paved the way for this advance was performed by Dr. Alex Travis, one of my current business partners, who spent more than 15 years studying male fertility and the critical process of capacitation, the process sperm must undergo to become able to fertilize an egg. I invite you to read more about capacitation and his discoveries here.

Based on his discoveries and the work of our passionate, knowledgeable team at Androvia, medical professionals will finally be able to determine the functional ability of sperm to fertilize the egg through a revolutionary laboratory developed test called the Cap-Score™ Sperm Function Test. This test determines one of the most important metrics within a semen analysis, the Cap-Score™, which assists couples and their medical professionals to make more personalized decisions than ever before about which fertility treatments may be best for them. It gives me great satisfaction to be a part of this solution for couples globally.

At Androvia LifeSciences, we are dedicated to improving the ability of reproductive health specialists and couples in better understanding the individual causes of infertility to help couples attain the gift of conceiving a child.

As pioneers in the practical application of capacitation for better understanding fertility, and one of the few companies in the world dedicated to male fertility, we are honored to assist you on the quest toward achieving conception, and the gift of life. We understand your frustration and are with you on your journey.

Sincerely,

Michael V. Novinski
Chief Executive Officer
Androvia LifeSciences LLC

Leadership Team

Michael V. Novinski

Co-Founder and Chief Executive Officer

View Profile

Alexander J. Travis, VMD, PHD

Co-Founder and Chief Scientific Officer

View Profile

Clinical Advisory Team

Gianpiero D. Palermo

Advisory Team Member

View Profile

Jay S. Schinfeld

Advisory Team Member

View Profile

Eric K. Seaman

Advisory Team Member

View Profile

Fady I. Sharara

Advisory Team Member

View Profile

Clinical and Research Team

Bryan Kloos

Laboratory Director, Technical Supervisor

View Profile

Romeo Mendoza

Laboratory Supervisor

View Profile

Melissa Moody

Laboratory Supervisor, QA/QC Manager, Research Scientist

View Profile

Alana Simpson

Laboratory Supervisor, Clinical Training Manager, Research Scientist

View Profile

Chuck Ostermeier

Senior Research Scientist

View Profile

Cristina Cardona

Research Scientist

View Profile



Engineering scientific technology for
the global advancement of male fertility.





Engineering scientific technology for the global advancement of male fertility.




Copyright by Androvia Lifesciences 2020. All rights reserved.


Copyright by Androvia Lifesciences 2020. All rights reserved.